| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
INTRACELLULAR SIGNAL SYSTEMS |
Unite Mixté de Recherche 6544 Centre National de la Recherche Scientifique (R.R., C.G., A.E.), Institut Fédératif Jean Roche, Faculté de Médecine Nord, 13916 Marseille Cedex 20; Unité Propre de Recherche 9023 Centre National de la Recherche Scientifique (M.N.D., V.H.) and U 469 Institut National de la Santé et de la Recherche Médicale (G.G.), Centre National de la Recherche Scientifique-Institut National de la Santé et de la Recherche Médicale de Pharmacologie-Endocrinologie, 34094 Montpellier Cedex, France
Address all correspondence and requests for reprints to: R. Rasolonjanahary, Interactions Cellulaires Neuroendocriniennes-Unité Mixte de Recherche UMR 6544 Centre National de la Recherche, Faculté de Médecine Nord, Bd Pierre Dramard, 13916 Marseille Cedex 20, France. E-mail: . rasolo.r{at}jean-roche.univ-mrs.fr
Dopamine (DA) is known to inhibit basal and hormone TRH- or angiotensin II (AngII)-stimulated PRL secretion and inositol phosphate accumulation in rat pituitary cells in primary culture. This inhibition persists when cells are incubated in a calcium-free medium (a condition in which DA could not inhibit PLC activities by blocking calcium influx) and is abolished by a Pertussis toxin treatment. These data suggest that DA receptor could be negatively coupled to PLC by a direct mechanism involving a Pertussis toxin-sensitive G protein. To demonstrate this hypothesis, we measured PLC activities on crude plasma membranes obtained from rat pituitary cells in primary culture grown in the presence of tritiated myo-inositol. We showed that 1) DA and quinpirole or RU24926 (specific D2 agonists) inhibited both basal and TRH- or AngII-stimulated membrane PLC activities. 2) Such inhibitions were completely prevented by sulpiride (specific D2 antagonist). 3) Heterotrimeric Gi1/2 proteins coupled the DA receptors to PLC because DA inhibitions were completely reversed by preincubation either with Pertussis toxin or with a specific G
i1/
i2 antibody. Such data are in favor of the existence of a direct negative coupling between DA-D2 receptor and PLC on a native physiological plasma membrane model.
This article has been cited by other articles:
![]() |
H.-W. Chang, V.-C. Wu, C.-Y. Huang, H.-Y. Huang, Y.-M. Chen, T.-S. Chu, K.-D. Wu, and B.-S. Hsieh D4 dopamine receptor enhances angiotensin II-stimulated aldosterone secretion through PKC-{varepsilon} and calcium signaling Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E622 - E629. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Romano, M. Pertuit, R. Rasolonjanahary, J.-V. Barnier, K. Magalon, A. Enjalbert, and C. Gerard Regulation of the RAP1/RAF-1/Extracellularly Regulated Kinase-1/2 Cascade and Prolactin Release by the Phosphoinositide 3-Kinase/AKT Pathway in Pituitary Cells Endocrinology, December 1, 2006; 147(12): 6036 - 6045. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wettschureck and S. Offermanns Mammalian G Proteins and Their Cell Type Specific Functions Physiol Rev, October 1, 2005; 85(4): 1159 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Beom, D. Cheong, G. Torres, M. G. Caron, and K.-M. Kim Comparative Studies of Molecular Mechanisms of Dopamine D2 and D3 Receptors for the Activation of Extracellular Signal-regulated Kinase J. Biol. Chem., July 2, 2004; 279(27): 28304 - 28314. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Albert Editorial: Dopamine-D2-Mediated Inhibition of TRH-Induced PLC Activation in Pituitary Cells--Direct or Indirect? Endocrinology, March 1, 2002; 143(3): 744 - 746. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |